fff,name,good.,countries,countries.comment,X,no.countries,group,group2,disease,all_host,host_type,secondary,secondary_type,all_vectors,vector_type,Type,CFR.low,CFR.high,cases_per_year,sporadic.endemic,X._cases_modelled,cases_per_yearx,spillover_rate_outbreaks,outbreaks_per_year,cases_per_year.1,first.date,R0,R0_ref,Incubation.low,Incubation.high,acute_low,acute_high,CFR.low.1,CFR.high.1,proportion.of.recovered.that.are.immmune,X..chronic.carrier,Chronicduration_low,Chronicduration_high,chronic.morbidity,Convalescence_length...non.infectious.recovery,reference,notes,reference.1,page,name2,spillover_rate2,final_weighting,AUC_cutoff,AUC,AUC_cutoffmax,AUCmax,AUC_cutoffmin,AUCmin,AUC_cutoff_real,AUC_real
197,guaroa,1,"BR,VE,PE,BO",0,"",11,California Group Virus disease,"","","","","","",anopheles neivai,"",HOST->VECTOR->HUMAN,0,0,0.0017,maybe,100,,"","",,,0,"",5,15,5,10,0.1,0.1,100,5,60,60,20,14,http://www.cdc.gov/lac/tech/fact.html,75 population have neutralising anitbodies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345823/; https://www.ncbi.nlm.nih.gov/pubmed/20810845; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929076/,82, guaroa,0.25,0.1,0.5304628024,0.407882365333333,0.63403891,0.433809333333333,0.544408363848258,0.389368888888889,,
